Loading...
H-CYTE, Inc.
HCYT•PNK
Healthcare
Biotechnology
$0.99
$-0.01(-0.50%)
H-CYTE, Inc. (HCYT) Stock Overview
Explore H-CYTE, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for HCYTStats details for HCYT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for HCYTAnalyst Recommendations details for HCYT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
CEO
Mr. Michael W. Yurkowsky
Employees
2
Headquarters
2202 North West Shore Boulevard, Tampa, FL
Founded
2014